Recent advances in pediatric acute lymphoblastic and myeloid leukemia.
about
Parental alcohol consumption and childhood cancers: a reviewPlatelet factor-4 is an indicator of blood count recovery in acute myeloid leukemia patients in complete remission.Are MTT assays the right tool to analyze drug resistance caused by ABC-transporters in patient samples?The Promise of Pharmacogenomics in Reducing Toxicity During Acute Lymphoblastic Leukemia Maintenance Treatment.Doxorubicin downregulates cell surface B7-H1 expression and upregulates its nuclear expression in breast cancer cells: role of B7-H1 as an anti-apoptotic moleculeBilateral proptosis and bitemporal swelling: A rare manifestation of acute myeloid leukemia.Biochemical modulation of aracytidine (Ara-C) effects by GTI-2040, a ribonucleotide reductase inhibitor, in K562 human leukemia cells.Engagement of SIRPα inhibits growth and induces programmed cell death in acute myeloid leukemia cells.Advancing pediatric psychiatry research: linking neurobiological processes to novel treatment and diagnosis through Research Domain Criteria (RDoC).MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemiaClofarabine in the treatment of acute myeloid leukaemia and acute lymphoblastic leukaemia: a review.Management of tumor lysis syndrome in adults.Variation in Risk of Hospital-Onset Clostridium difficile Infection Across β-Lactam Antibiotics in Children With New-Onset Acute Lymphoblastic Leukemia.Crenolanib is active against models of drug-resistant FLT3-ITD-positive acute myeloid leukemia.Phase II study of clofarabine in pediatric patients with refractory or relapsed acute myeloid leukemia.Risk factors for renal failure in pediatric patients with acute myeloid leukemia: a retrospective cohort study.The role of HDACs inhibitors in childhood and adolescence acute leukemias.Overview of therapy and strategies for optimizing outcomes in de novo pediatric acute myeloid leukemia.Acute myeloid leukemia presenting as bilateral proptosis and right temporal swelling.Hepatocyte growth factor receptor c-MET is associated with FAS and when activated enhances drug-induced apoptosis in pediatric B acute lymphoblastic leukemia with TEL-AML1 translocation.Oral health status, salivary pH status, and Streptococcus mutans counts in dental plaques and saliva of children with acute lymphoblastic leukemia.Unilateral eyelid swelling, proptosis and diplopia as initial manifestation of acute myeloid leukemia.Childhood proptosis: Relevance of aspiration cytology in the era of newer molecular diagnostic and imaging techniques.Inhibition of tumor necrosis factor-α enhances apoptosis induced by nuclear factor-κB inhibition in leukemia cells.Could intensified treatment in childhood acute lymphoblastic leukemia improve outcome independently of risk factors?Development of figurative language skills following central nervous system-directed chemotherapy delivered in early childhood.Detection and clinical significance of gene rearrangements in Chinese patients with adult acute lymphoblastic leukemia.Improved outcome in South African children of mixed ethnicity treated for all.Methotrexate-induced alterations in beta-oxidation correlate with cognitive abilities in children with acute lymphoblastic leukemia.Psychosocial life achievements in adults even if they received prophylactic cranial irradiation for acute lymphoblastic leukemia during childhood.Microarray-based classification of a consecutive series of 121 childhood acute leukemias: prediction of leukemic and genetic subtype as well as of minimal residual disease status.Apoptosis and proliferation differences between CD34+ and CD34- leukemic subpopulations in childhood acute leukemia.
P2860
Q28260772-8F6149EF-8225-4045-B4BF-BA7A36C959E1Q30838366-AF363F37-9D4F-4F6C-BE6D-FAC691D3DCCDQ33221958-7DFE5B83-57B1-4497-B943-DF66DC8F29FDQ33632120-F941C2DC-846B-4B70-9BAB-D213FBE733CCQ34173426-54D2CBD1-012A-4FD2-B0BA-12A9534599BAQ34244403-6A63AC71-C244-4E8E-8907-745FD4DE5D68Q34544604-5B0479AD-5DB2-4D43-B0D7-56EF47BBBA2CQ34548156-4E609401-CAE0-49EF-B4CF-BC7690DABD12Q36041881-3C9E62C5-FC2E-4E66-88E7-F3489FAE0065Q36288982-57296C08-0880-4520-B9EB-78905196AC2EQ36326258-07F3C1C7-B852-4FB3-B42E-7CDCE3A2330BQ36731440-F090516D-4881-4448-9FC7-8C4D3B528343Q36862305-D044664D-B0CC-407C-B4DB-D7E7EC82560CQ37334711-C229B62D-7E8A-4304-A345-DA458F92E698Q37347515-982DA5AE-1A71-42C9-B033-0E7154AA0579Q37541489-30549E80-829D-477B-96D9-B729F168853FQ37841146-020E6AB6-2AEE-42E1-9C73-001857C6BD6CQ38196743-1807BECC-2839-4015-B98E-19A0CA887773Q39186126-8F3E0C28-4275-4C55-AB6C-37816498CE0CQ40098619-CDF846DF-C860-4DA6-8696-800DC5612DBFQ40979175-A802BE12-5EE4-46D5-91B9-2F5462B6D765Q42161064-12FFA661-A14A-4035-9140-40FFAD7DAE95Q43074142-DBC3EE92-BAFE-40BB-8E3F-F3D99E316D04Q43147639-04BFDADA-E33F-4929-8F14-9ACB95ACDB25Q43487784-1E97F85E-7456-4F34-AA9C-2E8DC62C8CDAQ45397814-7ECD09B6-F687-4C1B-A921-DCB3309FFF50Q46091599-97C99F5D-C079-4646-A20E-31382D3F93A3Q46608506-97890B81-ED81-467B-B286-A5B61AB450C4Q46656584-D20D0566-F6E3-4986-B57A-7C44749E0288Q47974665-364B7162-0EE3-434B-A186-D7292E71A7E6Q50775513-20B51479-5731-4542-97F8-C78E8E1CFD14Q53528286-4C0D2F8F-B63E-41B7-B477-E1D0B318DD91
P2860
Recent advances in pediatric acute lymphoblastic and myeloid leukemia.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Recent advances in pediatric acute lymphoblastic and myeloid leukemia.
@ast
Recent advances in pediatric acute lymphoblastic and myeloid leukemia.
@en
type
label
Recent advances in pediatric acute lymphoblastic and myeloid leukemia.
@ast
Recent advances in pediatric acute lymphoblastic and myeloid leukemia.
@en
prefLabel
Recent advances in pediatric acute lymphoblastic and myeloid leukemia.
@ast
Recent advances in pediatric acute lymphoblastic and myeloid leukemia.
@en
P1476
Recent advances in pediatric acute lymphoblastic and myeloid leukemia.
@en
P2093
Yaddanapudi Ravindranath
P356
10.1097/00001622-200301000-00004
P577
2003-01-01T00:00:00Z